What Researchers Did
Researchers conducted a double-blind pilot randomized controlled trial with 34 acute ischemic stroke patients to evaluate the safety and efficacy of hyperbaric oxygen therapy compared to sham treatment over 10 daily sessions.
What They Found
The study randomized 34 patients, with 17 receiving hyperbaric oxygen and 17 receiving sham treatment. Baseline characteristics were similar between groups, and neurological deterioration occurred in 4 patients in the sham group during the first week.
What This Means for Canadian Patients
Given the incomplete abstract, the direct implications for Canadian patients regarding the efficacy of hyperbaric oxygen for acute ischemic stroke remain unclear. Further complete research is needed to determine if this therapy offers practical benefits for stroke recovery.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or participants.
Study Limitations
As a pilot study with a small sample size of 34 patients, the generalizability and statistical power of its findings are inherently limited.